相关实验视频

Updated: Sep 19, 2025

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

在异常后持续诊断不确定性的患者中正常[18F]FE-PE2I PET

Michiel Dhadamus¹, Aline Delva^2,3, Wies Deckers^1,4

¹Division of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.

Movement disorders : official journal of the Movement Disorder Society

|May 30, 2025

概括

使用[18F]FE-PE2I的正子发射断层扫描 (PET) 在大多数帕金森症患者和先前异常的[123I]FP-CIT SPECT扫描中显示出正常的多巴胺载体 (DAT) 图像. 这表明[18F]FE-PE2I PET可能有助于在持续不确定的情况下澄清诊断.

科学领域:

神经学神经学
放射学放射学是一门学科.
核医学就是核医学.

背景情况:

帕金森症诊断可能具有挑战性,特别是当用[123I]FP-CIT SPECT对多巴胺载体 (DAT) 成像异常,但临床进展异常时.
在一些患者中,尽管FP-CIT SPECT发现异常,但仍存在持续的诊断不确定性.

研究的目的:

评估新型正子发射断层扫描 (PET) DAT放射性连接体 [18F]FE-PE2I 在 [123I]FP-CIT SPECT 后未解决诊断问题的患者中的实用性.
在疑似帕金森症患者队列中评估[123I]FP-CIT SPECT和[18F]FE-PE2I PET之间的一致性.

主要方法:

对19名疑似帕金森症和诊断不确定性后[123I]FP-CIT SPECT患者的回顾性分析.
患者接受了[18F]FE-PE2I PET扫描 (平均在SPECT后3.7年).
通过对SPECT和PET扫描的视觉和半定量分析来评估一致性.

主要成果:

在视觉上,74%的异常[123I]FP-CIT SPECT患者显示正常[18F]FE-PE2I PET发现.
半定量分析表明,63%的异常[123I]FP-CIT SPECT的病例具有正常[18F]FE-PE2I PET结果.

结论:

[18F]FE-PE2I PET在异常[123I]FP-CIT SPECT后持续诊断不确定性的患者中通常是正常的.
这一发现表明[18F]FE-PE2I PET可能为完善复杂帕金森症病例的诊断提供有价值的补充信息.

关键词:

DAT (多巴胺转运体) 是一种多巴胺转运体.帕金森病的疾病.[123I]FP-CIT 公司 [18F]FE-PE2I 的时间.帕金森主义是帕金森主义.

更多相关视频

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...